Current FDA labels document these patterns in detail: Wegovy (semaglutide) lists nausea (44% vs 16% placebo), vomiting (25% vs 6%), diarrhea (30% vs 16%), constipation (24% vs 11%), abdominal distension and eructation, with severe GI events in 4.1% versus 0.9% placebo.[2] Zepbound (tirzepatide) lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, eructation, and gastroesophageal reflux disease among common adverse reactions, with severe GI disease as a Warnings and Precautions item.[3] Both labels include postmarketing reports of ileus, severe constipation including fecal impaction, and acute kidney injury related to dehydration from severe GI symptoms
Which makes you more susceptible to oxidative stress and tissue damage in the liver, as well as in other organs throughout your body
Even if theyre listing the right ingredients, you dont know where these ingredients are from or how theyve been transported or handled, which could be really dangerous. Lin and Ramachandran recommend that anyone seeking GLP-1 drugs consult with a physician both before they start and while theyre taking the medication to manage potential side effects, ensure safety and to make sure medication they receive is FDA-approved
Advanced Japanese Formula: Unique Manufacturing: Discuss the innovative lyophilized (freeze-dried) process that enhances the purity and potency of the Glutathione used in the injections
A3: When stored under recommended dry conditions in original sealed drums, the shelf life is typically 24 months from the date of manufacture
